Samsung Biologics Co.,Ltd. (KRX:207940)
South Korea · Delayed Price · Currency is KRW 1,477,000
-24,000 (-1.60%)
At close: Sep 3, 2026
Samsung Biologics Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 288,576 | 148,851 | 391,222 | 367,937 | 890,820 | 47,410 |
Short-Term Investments | 1,924,363 | 1,336,232 | 940,067 | 1,688,338 | 2,204,212 | 473,985 |
Trading Asset Securities | - | - | - | - | 98,506 | 850,040 |
Cash & Short-Term Investments | 2,212,938 | 1,485,083 | 1,331,289 | 2,056,276 | 3,193,537 | 1,371,435 |
Cash Growth | 34.55% | 11.55% | -35.26% | -35.61% | 132.86% | 60.96% |
Accounts Receivable | 573,774 | 654,728 | -0 | - | - | 0 |
Other Receivables | 41,997 | 21,739 | - | - | - | - |
Receivables | 615,771 | 676,467 | -0 | - | - | 0 |
Inventory | 2,344,406 | 2,128,164 | 2,818,276 | 2,641,368 | 2,375,819 | 1,012,871 |
Prepaid Expenses | 20,326 | 14,349 | 28,251 | 26,830 | 23,201 | 8,579 |
Other Current Assets | 137,704 | 104,304 | 1,340,302 | 797,513 | 865,099 | 430,291 |
Total Current Assets | 5,331,146 | 4,408,367 | 5,518,118 | 5,521,988 | 6,457,657 | 2,823,175 |
Property, Plant & Equipment | 6,748,009 | 6,037,532 | 5,837,482 | 4,342,424 | 3,871,452 | 2,227,687 |
Long-Term Investments | 51,944 | 78,325 | 59,605 | 47,435 | 38,110 | 2,661,499 |
Goodwill | - | - | 1,677,608 | 1,677,608 | 1,677,608 | - |
Other Intangible Assets | 76,794 | 60,193 | 1,294,705 | 1,580,423 | 1,541,850 | 32,172 |
Long-Term Accounts Receivable | - | - | 0 | 0 | -0 | 0 |
Long-Term Deferred Tax Assets | 148,771 | 132,837 | 165.09 | - | - | - |
Long-Term Deferred Charges | - | - | 2,592,990 | 2,574,057 | 2,741,848 | - |
Other Long-Term Assets | 295,924 | 343,458 | 355,592 | 302,236 | 253,524 | 225,477 |
Total Assets | 12,652,621 | 11,060,742 | 17,336,296 | 16,046,197 | 16,582,050 | 7,970,011 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 182,538 | 59,814 | 177,992 | 201,709 | 59,616 | 32,251 |
Accrued Expenses | 373,347 | 314,573 | 545,403 | 281,317 | 207,437 | 74,322 |
Short-Term Debt | 46,245 | - | 327,000 | 654,500 | 582,783 | 50,000 |
Current Portion of Long-Term Debt | 319,887 | 319,713 | - | 733,405 | 556,017 | 109,855 |
Current Portion of Leases | 40,404 | 7,258 | 138,594 | 144,031 | 142,247 | 7,537 |
Current Income Taxes Payable | 330,378 | 355,700 | 375,388 | 191,212 | 223,299 | 110,174 |
Current Unearned Revenue | - | - | 400,007 | 399,818 | 432,680 | - |
Other Current Liabilities | 1,673,348 | 1,475,860 | 1,888,804 | 1,551,870 | 1,977,462 | 723,156 |
Total Current Liabilities | 2,966,147 | 2,532,917 | 3,853,188 | 4,157,861 | 4,181,542 | 1,107,295 |
Long-Term Debt | 599,228 | 599,012 | 1,012,757 | 239,783 | 965,090 | 1,114,684 |
Long-Term Leases | 235,512 | 1,112 | 7,889 | 137,614 | 267,896 | 10,671 |
Pension & Post-Retirement Benefits | 7,273 | - | 5,547 | 5,117 | - | - |
Long-Term Deferred Tax Liabilities | 15,332 | - | 972,062 | 1,184,420 | 1,214,216 | 487,712 |
Other Long-Term Liabilities | 467,207 | 476,590 | 580,177 | 490,910 | 968,833 | 258,547 |
Total Liabilities | 4,290,698 | 3,609,631 | 6,431,620 | 6,215,705 | 7,597,576 | 2,978,909 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 115,727 | 115,727 | 177,935 | 177,935 | 177,935 | 165,413 |
Additional Paid-In Capital | 3,391,926 | 3,391,926 | 5,663,111 | 5,663,111 | 5,663,111 | 2,487,313 |
Retained Earnings | 7,770,860 | 6,870,961 | 5,086,609 | 4,003,293 | 3,145,601 | 2,347,187 |
Treasury Stock | - | -2,907,695 | - | - | - | - |
Comprehensive Income & Other | -2,916,591 | -19,809 | -22,979 | -13,847 | -2,173 | -8,811 |
Shareholders' Equity | 8,361,923 | 7,451,111 | 10,904,676 | 9,830,492 | 8,984,474 | 4,991,102 |
Total Liabilities & Equity | 12,652,621 | 11,060,742 | 17,336,296 | 16,046,197 | 16,582,050 | 7,970,011 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 1,241,275 | 927,094 | 1,486,239 | 1,909,333 | 2,514,033 | 1,292,747 |
Net Cash (Debt) | 971,664 | 557,989 | -154,951 | 146,943 | 679,504 | 78,688 |
Net Cash Growth | 328.40% | - | - | -78.38% | 763.54% | 17.19% |
Net Cash Per Share | 22307.74 | 12802.91 | -3347.32 | 3174.34 | 14965.87 | 1828.54 |
Filing Date Shares Outstanding | 46.24 | 46.24 | 46.29 | 46.29 | 46.29 | 43.03 |
Total Common Shares Outstanding | 46.24 | 46.24 | 46.29 | 46.29 | 46.29 | 43.03 |
Working Capital | 2,364,999 | 1,875,449 | 1,664,929 | 1,364,127 | 2,276,115 | 1,715,881 |
Book Value Per Share | 180839.32 | 161141.62 | 235568.21 | 212363.16 | 194087.06 | 115982.76 |
Tangible Book Value | 8,285,129 | 7,390,917 | 7,932,363 | 6,572,461 | 5,765,016 | 4,958,931 |
Tangible Book Value Per Share | 179178.53 | 159839.84 | 171358.83 | 141981.56 | 124538.73 | 115235.15 |
Land | 742,466 | 461,974 | 141,114 | 141,065 | 141,065 | - |
Buildings | 3,471,839 | 3,337,895 | 1,956,958 | 1,943,694 | 1,376,222 | 832,519 |
Machinery | 3,516,913 | 3,262,177 | 2,629,598 | 2,525,344 | 1,811,982 | 1,380,919 |
Construction In Progress | 365,164 | 430,161 | 1,833,097 | 202,411 | 825,199 | 583,360 |